GH1 and childhood malignant neoplasm: Nevertheless, in-vitro and in-vivo proliferative and pro-mitogenic properties of GH and insulin-like growth factor-1, which is produced following stimulation by GH, have raised concerns regarding potential associations between hGH use and the risk for tumor recurrence or subsequent malignancy in treated childhood cancer and brain tumor survivors.